Related Experiment Video
Updated: Aug 22, 2025

06:03
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
1.4K
Cellular Immuno-Profile in Septic Human Host: A Scoping Review
Christian Zanza1,2,3, Giorgia Caputo3, Gilda Tornatore4
1Foundation "Ospedale Alba e Bra", Department of Emergency Medicine, Anesthesia and Critical Care Medicine, Michele and Pietro Ferrero Hospital, 12060 Verduno, Italy.
Biology
|November 11, 2022
Summary
Sepsis triggers immune cell depletion and dysfunction. This review details current leukocyte analysis techniques and examines how blood purification therapies impact immune cell function in sepsis patients.
Area of Science:
- Immunology
- Critical Care Medicine
- Hematology
Background:
- Sepsis is a life-threatening condition involving immune system dysregulation.
- Apoptosis-induced immune cell depletion and immunodepression increase sepsis morbidity and mortality.
- Alterations in neutrophil and monocyte surface markers are observed in sepsis.
Purpose of the Study:
- To review current techniques for studying circulating leukocytes in sepsis.
- To analyze the impact of extracorporeal and non-blood purification treatments on leukocyte phenotype and function in sepsis.
Main Methods:
- Systematic literature review using major databases (PubMed/Medline, Embase, Cochrane Library, etc.).
- Inclusion of clinical trials and review articles from the last 50 years, excluding case reports.
- Focus on immunological function in sepsis and leukocyte alterations.
Main Results:
- Neutrophils in sepsis activate an anti-apoptotic survival program.
- Septic monocytes show reduced HLA-DR expression but largely preserved function.
- Sepsis induces lymphopenia and immunosuppression, affecting T cells (CD4, CD8, NK), but not regulatory T cells.
Conclusions:
- Understanding leukocyte alterations is crucial for sepsis management.
- Extracorporeal therapies, like the oXiris® filter, may mitigate sepsis severity by reducing inflammatory markers.
- Targeting host immune responses presents promising therapeutic avenues for sepsis.

